Otsuka (OTCMKTS:OTSKY) Shares Gap Up – Should You Buy?

Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY) gapped up prior to trading on Monday. The stock had previously closed at $34.88, but opened at $36.10. Otsuka shares last traded at $36.10, with a volume of 412 shares traded.

Otsuka Stock Performance

The company’s 50-day moving average price is $36.98 and its 200 day moving average price is $35.33. The stock has a market capitalization of $37.70 billion, a PE ratio of 14.09, a PEG ratio of 2.54 and a beta of 0.02. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.65 and a current ratio of 2.21.

Otsuka (OTCMKTS:OTSKY) last announced its quarterly earnings results on Friday, July 31st. The company reported $0.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.51 by $0.19. Otsuka had a net margin of 15.50% and a return on equity of 12.86%. The company had revenue of $4.41 billion for the quarter, compared to analysts’ expectations of $3.95 billion. Otsuka has set its FY 2026 guidance at 2.119-2.119 EPS. On average, equities research analysts expect that Otsuka Holdings Co., Ltd. – Unsponsored ADR will post 2.23 earnings per share for the current fiscal year.

Otsuka Company Profile

Otsuka Holdings Co, Ltd. is a Japan-based healthcare and consumer products group whose businesses span pharmaceuticals, nutraceuticals and consumer health products, as well as related medical and chemical activities. The company operates primarily through subsidiaries including Otsuka Pharmaceutical Co, Ltd. and serves customers in Japan and international markets.

Otsuka’s pharmaceutical operations focus on prescription medicines in areas such as psychiatry, oncology, nephrology, cardiovascular disease and several other therapeutic fields.